Furthermore, our findings highlighted the heterogeneity of anti-apoptotic dependency in DLBCL, in that CHOP treatment resulted in enhanced dependency, not only on BCL-2, but also on MCL-1 and BCL-XL. Here, BCL2 is linked to diffuse large B-cell lymphoma.